Search research articles
Contact Us
Filters
Showing results (11-20 of 364) with videos related to
Page
of 37
Sort By:
Cancer
|
July 1, 1995
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults
J P Droz, P Biron
Bulletin Du Cancer
|
September 4, 2010
[Rare tumours: a new heading in Bulletin du cancer]
C Massard, J-P Droz
Bulletin Du Cancer
|
January 1, 1995
[Dose intensity in anticancer chemotherapy. Paris, 19 December 1994]
J P Droz, D Maraninchi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1996
Adjuvant chemotherapy in pathologic Stage II nonseminomatous testicular cancer: are two cycles of etoposide-cisplatin a standard option?
S Culine, J P Droz
Bulletin Du Cancer
|
January 1, 1989
[Medical treatment of advanced cancers of the breast (metastatic and at metastatic high-risk)]
M Hayat, J P Droz
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
February 4, 2010
[Definition and outline on geriatric oncology]
C Terret, J-P Droz
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2001
Chemotherapy in advanced androgen-independent prostate cancer 1990-1999: a decade of progress?
S Culine, J P Droz
Bulletin Du Cancer
|
January 1, 1995
[Experience with other tumors: breast, ovary, brain tumors and sarcomas]
D Maraninchi, J P Droz
Annales D'Urologie
|
May 10, 2007
[Testis germ cell tumours: which chemotherapy, for which patients?]
A Fléchon, J P Droz
Bulletin Du Cancer
|
January 1, 1995
[Experience with non-Hodgkin's lymphoma]
P Biron, J P Droz
Page
of 37
Search research articles
Search
Showing results (11-20 of 364) with videos related to
Sort By:
Page
of 37
Cancer
|
July 1, 1995
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults
J P Droz, P Biron
Bulletin Du Cancer
|
September 4, 2010
[Rare tumours: a new heading in Bulletin du cancer]
C Massard, J-P Droz
Bulletin Du Cancer
|
January 1, 1995
[Dose intensity in anticancer chemotherapy. Paris, 19 December 1994]
J P Droz, D Maraninchi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1996
Adjuvant chemotherapy in pathologic Stage II nonseminomatous testicular cancer: are two cycles of etoposide-cisplatin a standard option?
S Culine, J P Droz
Bulletin Du Cancer
|
January 1, 1989
[Medical treatment of advanced cancers of the breast (metastatic and at metastatic high-risk)]
M Hayat, J P Droz
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
February 4, 2010
[Definition and outline on geriatric oncology]
C Terret, J-P Droz
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2001
Chemotherapy in advanced androgen-independent prostate cancer 1990-1999: a decade of progress?
S Culine, J P Droz
Bulletin Du Cancer
|
January 1, 1995
[Experience with other tumors: breast, ovary, brain tumors and sarcomas]
D Maraninchi, J P Droz
Annales D'Urologie
|
May 10, 2007
[Testis germ cell tumours: which chemotherapy, for which patients?]
A Fléchon, J P Droz
Bulletin Du Cancer
|
January 1, 1995
[Experience with non-Hodgkin's lymphoma]
P Biron, J P Droz
Page
of 37